Here's Why We're Not Too Worried About Compass Therapeutics' (NASDAQ:CMPX) Cash Burn Situation

By Yahoo! Finance | Jul 12, 2024 at 08:12 AM EST

Investing in unprofitable companies like Salesforce.com can be profitable, but caution is advised due to the risk of cash burn. Compass Therapeutics (NASDAQ:CMPX) had a 3.7-year cash runway as of March 2024, but its increasing cash burn rate raises concerns.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.